858 results on '"Lichtenberg, Artur"'
Search Results
2. Hydrogel-coated and active clearance chest drains in cardiac surgery: real-world results of a single-center study
3. Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation
4. Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease
5. Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial
6. Outcome of patients supported with the HeartMate 3 after extracorporeal life support: On behalf of the Durable Mechanical Circulatory Support After Extracorporeal Life Support Study Group
7. Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation
8. Combining aortic arch dissection stent implantation and root surgery for aortic dissection type A
9. Presence and impact of anemia in patients supported with left ventricular assist devices
10. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
11. Coronary artery bypass grafting under sole Impella 5.0 support for patients with severely depressed left ventricular function
12. Less-invasive ventricular assist device implantation: A multicenter study
13. Virulence of Staphylococcus Infection in Surgically Treated Patients With Endocarditis: A Multicenter Analysis
14. Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation With and Without Intra-Aortic Balloon Pump
15. Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis
16. Validation of days alive and out of hospital as a new patient-centered outcome to quantify life impact after heart transplantation
17. Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection
18. Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO
19. Aortic and Mitral Valve Endocarditis—Simply Left-Sided Endocarditis or Different Entities Requiring Individual Consideration?—Insights from the CAMPAIGN Database.
20. The Predictive Role of Metabolic Volume Segmentation Compared to Semiquantitative PET Parameters in Diagnosis of LVAD Infection using [18F]FDG Imaging.
21. Model for End-Stage Liver Disease Including Na, Age, and Sex Is Powerful Predictor of Survival in COVID-19 Patients on Extracorporeal Membrane Oxygenation.
22. Neurologic Injury in Patients Treated With Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock
23. Duration of Venoarterial Extracorporeal Membrane Oxygenation and Mortality in Postcardiotomy Cardiogenic Shock
24. Stroke Complications in Patients Requiring Durable Mechanical Circulatory Support Systems After Extracorporeal Life Support
25. Virulence of Staphylococcus Infection in Surgically Treated Patients With Endocarditis: A Multicenter Analysis
26. Impact of psoas muscle evaluation on clinical outcomes in patients undergoing left ventricular assist device implantation
27. Transition From Temporary to Durable Circulatory Support Systems
28. Impact of tricuspid valve insufficiency on the performance of left ventricular assist devices
29. Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model.
30. Feasibility, Accuracy, and Reproducibility of Aortic Valve Sizing for Transcatheter Aortic Valve Implantation Using Virtual Reality.
31. Outcomes following heart valve surgery in patients with infective endocarditis and preoperative septic cerebral embolism: insights from the CAMPAIGN study group.
32. Sex-related differences in patients with infective endocarditis requiring cardiac surgery: insights from the CAMPAIGN Study Group.
33. Changes in Therapy and Outcome of Patients Requiring Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19.
34. The Impact of Intraoperative Patient Blood Management on Quality Development in Cardiac Surgery
35. Fibrinolysis and the Influence of Tranexamic Acid Dosing in Cardiac Surgery
36. Venoarterial Extracorporeal Membrane Oxygenation After Surgical Repair of Type A Aortic Dissection
37. Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation
38. Health-related quality of life after heart surgery – Identification of high-risk patients: A cohort study
39. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19
40. Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing
41. Fibrinogen–Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO
42. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing
43. Impact of standardized computed tomographic angiography for minimally invasive mitral and tricuspid valve surgery
44. A role for peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonists in counteracting the degeneration of cardiovascular grafts
45. Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial
46. Impact of hyperinsulinemia and hyperglycemia on valvular interstitial cells – A link between aortic heart valve degeneration and type 2 diabetes
47. Five-year results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement—the ARISE Study and ARISE Registry Data.
48. Somatic Development in Children with Congenital Heart Defects
49. Transfer of a minimally invasive mitral valve repair program from a high-volume center to a very low volume center: how many cases are necessary to maintain acceptable results?
50. Four-year experience of providing mobile extracorporeal life support to out-of-center patients within a suprainstitutional network—Outcome of 160 consecutively treated patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.